TERN: Terns Pharmaceuticals, Inc. Stock

by  •  • Comments Off on TERN: Terns Pharmaceuticals, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 262.77
Enterprise Value ($M) 101.33
Book Value ($M) 326.04
Book Value / Share 3.96
Price / Book 0.76
NCAV ($M) 324.48
NCAV / Share 3.72
Price / NCAV 0.81

Profitability (mra)
Return on Invested Capital (ROIC) -0.26
Return on Assets (ROA) -0.36
Return on Equity (ROE) -0.38

Liquidity (mrq)
Quick Ratio 23.14
Current Ratio 23.14

Balance Sheet (mrq) ($M)
Current Assets 337.75
Assets 339.31
Liabilities 13.27
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -101.87
Net Income -88.85

Cash Flow Statement (mra) ($M)
Cash From Operations -70.02
Cash from Investing -12.41
Cash from Financing 164.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
2 days ago 13G Morgan Stanley 8.10
02-14 13G/A Citadel Advisors Llc 4.10
02-14 13G/A Schonfeld Strategic Advisors LLC 6.16
02-11 13G/A Soleus Capital Master Fund, L.P. 9.60 30.83
02-05 13G/A BlackRock, Inc. 6.80 22.23
11-14 13G/A Vivo Capital Fund VIII, L.P. 5.40
11-14 13G/A Venrock Healthcare Capital Partners III, L.P. 4.99 -21.80
11-14 13G/A Fairmount Funds Management LLC 0.00 -100.00
11-14 13G/A Suvretta Capital Management, Llc 0.00 -100.00
11-14 13G/A Point72 Asset Management, L.P. 3.50 -26.19
11-05 13G/A Integrated Core Strategies (us) Llc 1.90 -53.20
09-16 13D/A Orbimed Advisors Llc 9.00 0.00

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-05-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2025-03-20 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2024-11-12 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-08-05 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-05-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-05-08 132,336 544,680 24.30
2025-05-07 173,535 564,776 30.73
2025-05-06 248,002 967,375 25.64
2025-05-05 157,845 776,374 20.33

(click for more detail)

Similar Companies
SYRE – Spyre Therapeutics, Inc. TARS – Tarsus Pharmaceuticals, Inc.
TECH – Bio-Techne Corporation TLRY – Tilray Brands, Inc.
TNYA – Tenaya Therapeutics, Inc.


Financial data and stock pages provided by
Fintel.io